Covid 19 Related Resource
What do these findings mean?
Dr. Russo says. “We’ve been struggling both to diagnose long COVID and to treat it. This study lends some support.”
Doctors say that the study’s findings are a big deal. “This is a really important study,” Dr. Russo says. “We’ve been struggling both to diagnose long COVID and to treat it. This study lends some support.”
How? It could help provide a basis for future diagnostic tests and even treatments, Dr. Adalja says.
Essentially, once scientists know what causes a condition like long COVID, they can go to work finding ways to heal people who have it.
Dr. Adalja also points out: “There are existing drugs that target [the] complement” system.
But while Dr. Russo says the findings are very likely to be helpful to many long COVID patients, he also says the complement system may not be involved in all long COVID patients.
“I have no doubt that, with long COVID, one size does not fit all,” he says. “But this has the potential to perhaps be part of a diagnostic test for at least some patients.”
ALERT
“Millions of people across the planet have long COVID or will develop it,” he says. “It’s going to be the next major phase of this pandemic. If we don’t learn to diagnose and manage this, we are going to have many people with complications that impact their lives for the long term.”
COPYRIGHT © 2019 SISTERS IN COMMON